Association of decrease in serum dehydroepiandrosterone sulfate levels with the progression to type 2 diabetes in men of a Japanese population: The Fungata Study

Metabolism: Clinical and Experimental

Volumn 54, Issue 5, 2005, Pages 669-676

  Kameda, Wataru ^a   Daimon, Makoto ^a   Oizumi, Toshihide ^a   Jimbu, Yumi ^a   Kimura, Minako ^a   Hirata, Akihiko ^a   Yamaguchi, Hiroshi ^a   Ohnuma, Hiroshi ^a   Igarashi, Masahiko ^a   Tominaga, Makoto ^a   Kato, Takeo ^a  

^a YAMAGATA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PRASTERONE SULFATE;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BODY HEIGHT; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE COURSE; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; HORMONE BLOOD LEVEL; HUMAN; JAPAN; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; WORLD HEALTH ORGANIZATION;

EID: 20244382828     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2004.12.011     Document Type: Article

References (33)

1. P. Ebeling, and V.A. Koivisto Physiological importance of dehydroepiandrosterone Lancet 343 1994 1479 1481
2. K. Barrett-Connor, K.T. Khaw, and S.S. Yen A prospective study of dehydroepiandrosterone sulfate, mortality, and cardiovascular disease N. Engl. J. Med. 315 1986 1519 1524
3. L.E. Mitchell, D.L. Sprecher, and I.B. Borecki Evidence for an association between dehydroepiandrosterone sulfate and nonfatal, premature myocardial infarction in males Circulation 89 1994 89 93
4. H.A. Feldman, C.B. Johannes, and A.B. Araujo Low dehydroepiandrosterone and ischemic heart diseases in middle-ages men: Prospective results from the Massachusetts Male Aging Study Am. J. Epidemiol. 153 2001 79 89
5. N. Orentreich, J.L. Brind, and R.L. Rizer Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood J. Clin. Endocrinol. Metab. 59 1984 551 555
6. R.I. Fink, O.G. Kolterman, and J. Griffin Mechanism of insulin resistance in aging J. Clin. Invest. 71 1983 1523 1535
7. J.W. Rowe, K.L. Minaker, and J.A. Pallotta Characterization of the insulin resistance in aging J. Clin. Invest. 71 1983 1581 1587
8. G. Paolisso, S. Ammendola, and M. Rotondi Insulin resistance and advancing age: What role for dehydroepiandrosterone sulfate? Metabolism 46 1997 1281 1286
9. M. Barbieri, M.R. Rizzo, and D. Manzella Age-related insulin resistance: Is it an obligatory finding? The lesson from healthy centenarians Diabetes Metab. Res. Rev. 17 2001 19 26
10. D.P. Williams, T.W. Boyden, and R.W. Pamenter Relationship of body fat percentage and far distribution with dehydroepiandrosterone sulfate in premenopausal women J. Clin. Endocrinol. Metab. 77 1993 80 85
11. S.M. Haffner, R.A. Valdez, and L. Mykkanen Decreased testosterone and dehydroepiandrosterone sulfate concentrations are associated with increased insulin and glucose concentrations in nondiabetic men Metabolism 43 1994 599 603
12. C.K. Buffington, J.R. Givens, and A.E. Kitabchi Opposing actions of dehydroepiandrosterone and testosterone on insulin sensitivity. In vivo and in vitro studies of hyperandrogenic females Diabetes 40 1991 693 700
13. D.L. Coleman, E.H. Leiter, and R.W. Schwizer Therapeutic effects of dehydroepiandrosterone (DHEA) in diabetic mice Diabetes 31 1982 830 833
14. A. Shepherd, and M.P. Cleary Metabolic alterations after dehydroepiandrosterone treatment in Zucker rats Am. J. Physiol. 246 1984 E123 E128
15. C.K. Buffington, G. Pourmotabbed, and A.E. Kitabchi Case report: Amelioration of insulin resistance in diabetes with dehydroepiandrosterone Am. J. Med. Sci. 306 1993 320 324
16. E.D. Schriock, C.K. Buffington, and G.D. Hubert Divergent correlations of circulating dehydroepiandrosterone sulfate and testosterone with insulin levels and insulin receptor binding J. Clin. Endocrinol. Metab. 66 1998 1329 1331
17. J.S. Dillon, G.C. Yaney, and Y. Zhou Dehydroepiandrosterone sulfate and β-cell function: Enhanced glucose-induced insulin secretion and altered gene expression in rodent pancreatic β-cells Diabetes 49 2000 2012 2020
18. M. Daimon, T. Oizumi, and T. Saitoh Decreased serum levels of adiponectin are a risk factor for the progression to type 2 diabetes in the Japanese population Diabetes Care 26 2003 2015 2020
19. S.A. Jebb, T.J. Cole, and D. Doman Evaluation of the novel Tanita body-fat analyzer to measure body composition by comparison with a four-compartment model Br. J. Nutr. 83 2000 115 122
20. World Health Organization Diabetes mellitus: Report of a WHO Study Group [Technical Report Series No. 727] 1985 World Health Organization Geneva
21. W.E. Rainey, B.R. Carr, and H. Sasano Dissecting human adrenal androgen production Trends Endocrinol. Metab. 13 2002 234 239
22. G. Ravaglia, P. Forti, and F. Maioli Dehydroepiandrosterone-sulfate serum levels and common age-related diseases: Results from a cross-sectional Italian study of a general elderly population Exp. Gerontol. 37 2002 701 712
23. A. Abbasi, E.H. Duthie Jr., and L. Sheldahl Association of dehydroepiandrosterone sulfate, body composition, and physical fitness in independent community-dwelling older men and women J. Am. Geriatr. Soc. 46 1998 263 273
24. S. Kiechl, J. Willeit, and E. Bonora No association between dehydroepiandrosterone sulfate and development of atherosclerosis in a prospective population study (Bruneck Study) Arterioscler. Thromb. Vasc. Biol. 20 2000 1094 1100
25. S. Salvini, M.J. Stampfer, and R.L. Barbieri Effect of age, smoking, and vitamins on plasma DHEAS levels: A cross-sectional study in men J. Clin. Endocrinol. Metab. 74 1992 139 143
26. A.E. Field, G.A. Colditz, and W.C. Willet The relation of smoking, age, relative weight, and dietary intake to serum adrenal steroids, sex hormones, and sex hormone-binding globulin in middle-aged men J. Clin. Endocrinol. Metab. 79 1994 1310 1316
27. J.F. Mortola, and S.S. Yen The effect of oral dehydroepiandrosterone on endocrine-metabolic parameters in post-menopausal women J. Clin. Endocrinol. Metab. 71 1990 696 704
28. A.J. Morales, J.J. Nolan, and J.C. Nelson Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age J. Clin. Endocrinol. Metab. 78 1994 1360 1367
29. M.A. Flynn, D. Weaver-Osterholtz, and K.L. Sharpe-Timms Dehydroepiandrosterone replacement in aging humans J. Clin. Endocrinol. Metab. 84 1999 1527 1533
30. E. Barrett-Connor, and A. Ferrara Dehydroepiandrosterone, dehydroepiandrosterone sulfate, obesity, waist-hip ratio, and noninsulin-dependent diabetes in postmenopausal women: The Rancho Bernardo study J. Clin. Endocrinol. Metab. 81 1996 59 64
31. M. Saruç, H. Yüceyar, and S. Ayhan The association of dehydroepiandrosterone, obesity, waist-hip ratio and insulin resistance with fatty liver in postmenopausal women-a hyperinsulinemic euglycemic insulin clamp study Hepatogastroenterology 50 2003 771 774
32. A. Dunaif, and A. Thomas Current concepts in the polycystic ovary syndrome Annu. Rev. Med. 52 2001 401 419
33. B.O. Yildiz, H. Yarali, H. Oguz, and M. Bayraktar Glucose intolerance, insulin resistance, and hyperandrogenemia in first degree relatives of women with polycystic ovary syndrome J. Clin. Endocrinol. Metab. 88 2003 2031 2036